Successful end Phase 1 of the European precommercial public procurement project ROSIA-PCP

Successful end Phase 1 of the European precommercial public procurement project ROSIA-PCP

Successful end Phase 1 of the European precommercial public procurement project ROSIA-PCP

End Phase 1 of the European precommercial public procurement project ROSIA-PCP
ROSIA-PCP announces the successful and promising closure of Phase 1 of the European precommercial public procurement project ROSIA
  • Pre-commercial public procurement is a phased R&D competition in which several public administrations define a common need not covered by the market.
  • ROSIA aims to unlock the telerehabilitation market through the development of an innovation ecosystem that enables the integration of public health services with patient self-care and self-management tools and community services.
  • Phase 1 aimed at the detailed design of the solution, phase 2 will consist of the development of the prototype and phase 3 the validation of the complete solution. The total funding is €3.9M.
Zaragoza, 23 February 2023. ROSIA has successfully completed phase 1 of the competition that started on 28 October 2022 with the publication on TED (Tenders Electronic Daily) of the five winning bidders from the ‘Open Tender’ process.  All five have successfully completed this stage with proposals based on open platforms, cutting-edge technologies and highly innovative approaches that bring us closer to data-driven health, the use of sensors and the enormous potential of mobile phones. ROSIA (Remote Rehabilitation for Isolated Areas) is a project co-funded by the European Union’s H2020 research and innovation programme under the pre-commercial public procurement (PCP) instrument and agreement GA 101017606. The three public bodies participating in the ROSIA project procurement team are the Aragonese Health Service, the National Rehabilitation Hospital (Ireland) and the Centro Hospitalar e Universitário de Coimbra.  The Instituto Aragonés de Ciencias de la Salud (IACS) is leading the project and executing the joint procurement procedure on behalf of all three organisations. The five contractors involved in this phase are:

RAISE is the name of the proposal led by the Greek entity CERTH (Centre For Research And Technology Hellas), which also integrates the Spanish TELEVES, IBV and Vidavo, the Greek Research Committee University Ioannina (UoI) and Trilateral Research, and the Portuguese INESCTEC.

– The Spanish technology centre Eurecat is leading the PROHAB proposal, which also involves two other Spanish entities, the SME Doole Health, and the Germans Trias i Pujol research centre (IGTP).

– The Spanish companies Bahia Software and Rehametric are presenting under the ULTREIA proposal, led by the former.

– The most international consortium is led by the Greek technology centre; Foundation For Research And Technology Hellas (FORTH) and includes the SMEs DyCare (Spain), Konnektable Technologies (Ireland), LifeCharger (Italy), Wellics (UK); the companies PDMFC Group (Portugal) and Uni Systems (Greece).

– The fifth successful bidder is the Spanish company GMV, which submitted Rehabilita+.

The first implementation phase lasted three months and each contractor signed a €20,000 contract to develop the design of their proposed solution. During this period, a team made up of representatives of the three purchasers closely followed the evolution, resolving doubts and giving recommendations to the contractors for the alignment of their proposals with the shared needs of the purchasers. To access the next phase, these contractors will have to go through a new evaluation of their proposals, in which only three of the contractors will be selected and will have a budget of €300,000 (including 21% VAT) each, to be carried out between March-April 2023 and February-January 2024. The results obtained and the lessons learned during the project execution will help the deployment of a telerehabilitation solutions platform, easily integrated into any health service in Europe. In the future, the applications and devices of the ROSIA Catalogue will be connected to this platform, allowing the integration of community and supervised self-care services into the care plan of each patient. The ROSIA model of integrated value-based care can also open the door to rethinking new business models and incentives for providers, improve equity in access to rehabilitation resources and contribute to improving the sustainability of these services.
 
Procedure for Unsolicited Offers

Procedure for Unsolicited Offers

Procedure for Unsolicited Offers

Procedure for Unsolicited Offers

Since the beginning of project ROSIA, several economic operators have contacted ROSIA’s partners to present unsolicited offers to the Consortium .

Procedure for unsolicited Offers to the Consortium

Since the beginning of project ROSIA , several economic operators have contacted ROSIA’s partners to present unsolicited offers to the Consortium.

The objective of this procedure is protocoling how these unsolicited offers can be presented within the Consortium, within the phase of analysis of the state of the art, guaranteeing that all offers that could be interesting for the project are analysed without prejudice to the principles governing public procurement.

During the preparatory phase of the tender there are two fundamental stages in which to gather information about the market:

Analysis of State of the Art:
The aim of this task is to analyse and review the progress on the State of the Art (SOTA) in the main areas relevant for ROSIA with the main objectives of feeding into project ROSIA ensuring solutions remain ground‐breaking, facilitating the building up of the common challenge, and identifying potential players for development of the critical mass.

Market development and engagement:
These activities have two main objectives: first, engage potential applicants to participate in ROSIA’s challenge, participating in the co‐creation of ROSIA’s model through the OMC activities, and to submit bids for ROSIA`s PCP challenge; second, allow ROSIA’s partners to review and refine ROSIA’s model with the market insight.

So this is the crucial moment for interaction with companies, through a procedure governed by the conditions established in articles 40 and 41 of directive 24/2014 Directive 2014/24/EU of the European Parliament and of the Council of 26 February 2014 on public procurement.

We have defined a procedure of interaction with economic operators until the publication of the OMC that contributes to the identification of potential players that SOTA (State of the Art) is carrying out, respecting the principles that govern public procurement.

What is the Procedure:

  1. This procedure will be published in ROSIA’s website. A web form will be designed for the economic operators to complete, identifying the company’s name, their solution and their contact information. They could upload any information they consider of interest for the Consortium.
  2. This web form and the possibility of uploading documentation will be available until the OMC is launched.
  3. It is mandatory that economic operators understand that
    • a) The competitive phase of the public procurement procedure is conducted at the tender, where all potential bidders will be treated equally.
    • b) Before the tender, an OMC will be held in which the public procurer will pro-actively communicate its needs, requirements and its planned procurement set-up to all participants and economic operators will be able to present their solutions to the Consortium. The participation of potential bidders in the OMC must not affect competition in the future tender procedure.
    • c) Until the OMC is launched, the Consortium has established this procedure to broaden the knowledge of prospective players in for development of the critical mass in the State-of-The-Art analysis. These interaction activities must not affect competition in the future tender procedure.

This statement should be written in the acceptance of any request to show a solution by economic operators to economic operators.

4. All documentation received will be analysed by the Consortium and included in SOTA Analysis, if relevant.  Documentation will be shared internally with all ROSIA’s partners.

THIS PROCEDURE WAS CLOSED WHEN OMC STARTED

PCP Execution Phases

PCP Execution Phases

PCP Execution Phases

PCP Execution Phases

The ROSIA PCP will implement an effective and efficient methodological approach to ensure the successful preparation and conduction of the pre-commercial procurement and to lay the foundations for large-scale procurement of the fully developed ROSIA solutions after the duration of the PCP.

PCP Execution Phases

Pre-commercial procurement (PCP) is the procurement of research and development of new innovative solutions before they are commercially available. PCP involves different suppliers competing through different phases of development. The risks and benefits are shared between the procurers and the suppliers under market conditions. PCP Execution Phases

Public procurers involved in the ROSIA project have the common goal to deliver disruptive solutions to support effective implementation of scalable and cost-effective telerehabilitation solutions for people living in rural areas requiring long-term and tailored rehabilitation treatments, throughout the implementation of a Pre-Commercial Procurement scheme (PCP). The project will make progress towards this aim by stimulating the demand and creating a robust framework for practical PCP outcomes within the project duration. This will also promote innovation in Europe, via demand through the PCP, which has, so far, been an under-utilized tool.

The ROSIA PCP process will start with an extensive preparation stage and is followed by the execution stage organized in three development phases. The preparation stage (PHASE 0) includes the Prior information Notice Publication (PIN) and the Open Market Consultation (OMC).

The execution stage will consist of: a joint PCP procurement process and the implementation, in three phases, of the PCP contracts under the supervision of the buyers’ group, ensuring execution of the R&D services by the providers according to the action plan, implementation, and requirements defined in the preparation stage.

  • PHASE 1 Solution design will develop the feasibility study of selected solutions from awarded bidders. Duration: 3 months
  • PHASE 2 Prototyping development of most promising solutions from PHASE 1. Duration: 8 months
  • PHASE 3 Pre-commercial small scale solution deployment – Field test. Validation of best prototyped solutions in real life scenario at each procurer site. Duration: 18 months.

PCP Execution Phases